TY - JOUR
T1 - Lifestyle Interventions for the Prevention of Parkinson Disease
T2 - A Recipe for Action
AU - Janssen Daalen, Jules M.
AU - Schootemeijer, Sabine
AU - Richard, Edo
AU - Darweesh, Sirwan K. L.
AU - Bloem, Bastiaan R.
N1 - Funding Information: The Article Processing Charge was funded by Massachusetts General Hospital. Funding Information: The Centre of Expertise for Parkinson's Disease & Movement Disorders was supported by a Center of Excellence grant of the Parkinson's Foundation. J.M. Janssen Daalen was supported by a Therapeutic Pipeline Program research grant of the Michael J. Fox Foundation (grant ID 019201). S. Schootemeijer and B.R. Bloem were supported by a research grant of the Netherlands Organization for Health Research and Development (ZonMw). E. Richard received a personal VIDI grant of the Netherlands Organization for Health Research and Development (91718303). S.K.L. Darweesh was supported in part by a Parkinson's Foundation- Postdoctoral Fellowship (PF-FBS-2026). Go to Neurology.org/N for full disclosures. Publisher Copyright: © American Academy of Neurology.
PY - 2022/8/16
Y1 - 2022/8/16
N2 - The prevalence of Parkinson disease (PD) is growing fast, amplifying the quest for disease-modifying therapies in early disease phases where pathology is still limited. Lifestyle interventions offer a promising avenue for preventing progression from prodromal to manifest PD. We illustrate this primarily for 1 specific lifestyle intervention, namely aerobic exercise because the case for the other main lifestyle factor (dietary interventions) to modify the course of prodromal PD is currently less persuasive. Various observations have hinted at the disease-modifying potential of exercise. First, studies in rodents with experimental parkinsonism showed that exercise elicits adaptive neuroplasticity in basal ganglia circuitries. Second, exercise is associated with a reduced risk of developing PD, suggesting a disease-modifying potential. Third, 2 large trials in persons with manifest PD indicate that exercise can help to stabilize motor parkinsonism, although this could also reflect a symptomatic effect. In addition, exercise seems to be a feasible intervention, given its minimal risk of side effects. Theoretical risks include an increase in fall incidents and cardiovascular complications, but these concerns seem to be acceptably low. Innovative approaches using gamification elements indicate that adequate long-term compliance with regular exercise programs can be achieved, although more work remains necessary to demonstrate enduring adherence for multiple years. Advances in digital technology can be used to deliver the exercise intervention in the participant's own living environment and also to measure the outcomes remotely, which will help to further boost long-term compliance. When delivering exercise to prodromal participants, outcome measures should focus not just on phenoconversion to manifest PD (which may well take many years to occur) but also on measurable intermediate outcomes, such as physical fitness or prodromal nonmotor symptoms. Taken together, there seems to be sufficient evidence to advocate the first judicious attempt of investigating exercise as a disease-modifying treatment in prodromal PD.
AB - The prevalence of Parkinson disease (PD) is growing fast, amplifying the quest for disease-modifying therapies in early disease phases where pathology is still limited. Lifestyle interventions offer a promising avenue for preventing progression from prodromal to manifest PD. We illustrate this primarily for 1 specific lifestyle intervention, namely aerobic exercise because the case for the other main lifestyle factor (dietary interventions) to modify the course of prodromal PD is currently less persuasive. Various observations have hinted at the disease-modifying potential of exercise. First, studies in rodents with experimental parkinsonism showed that exercise elicits adaptive neuroplasticity in basal ganglia circuitries. Second, exercise is associated with a reduced risk of developing PD, suggesting a disease-modifying potential. Third, 2 large trials in persons with manifest PD indicate that exercise can help to stabilize motor parkinsonism, although this could also reflect a symptomatic effect. In addition, exercise seems to be a feasible intervention, given its minimal risk of side effects. Theoretical risks include an increase in fall incidents and cardiovascular complications, but these concerns seem to be acceptably low. Innovative approaches using gamification elements indicate that adequate long-term compliance with regular exercise programs can be achieved, although more work remains necessary to demonstrate enduring adherence for multiple years. Advances in digital technology can be used to deliver the exercise intervention in the participant's own living environment and also to measure the outcomes remotely, which will help to further boost long-term compliance. When delivering exercise to prodromal participants, outcome measures should focus not just on phenoconversion to manifest PD (which may well take many years to occur) but also on measurable intermediate outcomes, such as physical fitness or prodromal nonmotor symptoms. Taken together, there seems to be sufficient evidence to advocate the first judicious attempt of investigating exercise as a disease-modifying treatment in prodromal PD.
UR - http://www.scopus.com/inward/record.url?scp=85136005365&partnerID=8YFLogxK
U2 - https://doi.org/10.1212/WNL.0000000000200787
DO - https://doi.org/10.1212/WNL.0000000000200787
M3 - Article
C2 - 35970584
SN - 0028-3878
VL - 99
SP - S42-S51
JO - Neurology
JF - Neurology
IS - 7
ER -